These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 23614548)

  • 1. Uncertainty in QSAR predictions.
    Sahlin U
    Altern Lab Anim; 2013 Mar; 41(1):111-25. PubMed ID: 23614548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arguments for considering uncertainty in QSAR predictions in hazard and risk assessments.
    Sahlin U; Golsteijn L; Iqbal MS; Peijnenburg W
    Altern Lab Anim; 2013 Mar; 41(1):91-110. PubMed ID: 23614547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Risk Assessment Perspective of Current Practice in Characterizing Uncertainties in QSAR Regression Predictions.
    Sahlin U; Filipsson M; Öberg T
    Mol Inform; 2011 Jun; 30(6-7):551-64. PubMed ID: 27467156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. QSAR Use in REACH Analyses of Alternatives to Predict Human Health and Environmental Toxicity of Alternative Chemical Substances.
    Chinen K; Malloy T
    Integr Environ Assess Manag; 2020 Sep; 16(5):745-760. PubMed ID: 32162772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and description of the uncertainty, variability, bias and influence in quantitative structure-activity relationships (QSARs) for toxicity prediction.
    Cronin MTD; Richarz AN; Schultz TW
    Regul Toxicol Pharmacol; 2019 Aug; 106():90-104. PubMed ID: 31026540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The implementation of RAAF in the OECD QSAR Toolbox.
    Kuseva C; Schultz TW; Yordanova D; Tankova K; Kutsarova S; Pavlov T; Chapkanov A; Georgiev M; Gissi A; Sobanski T; Mekenyan OG
    Regul Toxicol Pharmacol; 2019 Jul; 105():51-61. PubMed ID: 30970268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of a quantitative structure-activity relationship for chronic narcosis to fish.
    Claeys L; Iaccino F; Janssen CR; Van Sprang P; Verdonck F
    Environ Toxicol Chem; 2013 Oct; 32(10):2217-25. PubMed ID: 23775559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting the hazardous dose of industrial chemicals in warm-blooded species using machine learning-based modelling approaches.
    Gupta S; Basant N; Singh KP
    SAR QSAR Environ Res; 2015 Jun; 26(6):479-98. PubMed ID: 26087353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Species Sensitivity Distribution estimation from uncertain (QSAR-based) effects data.
    Aldenberg T; Rorije E
    Altern Lab Anim; 2013 Mar; 41(1):19-31. PubMed ID: 23614542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing predictive uncertainty in comparative toxicity potentials of triazoles.
    Golsteijn L; Iqbal MS; Cassani S; Hendriks HW; Kovarich S; Papa E; Rorije E; Sahlin U; Huijbregts MA
    Environ Toxicol Chem; 2014 Feb; 33(2):293-301. PubMed ID: 24122976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated testing and intelligent assessment-new challenges under REACH.
    Ahlers J; Stock F; Werschkun B
    Environ Sci Pollut Res Int; 2008 Oct; 15(7):565-72. PubMed ID: 18818964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Internal and external validation of the long-term QSARs for neutral organics to fish from ECOSAR™.
    de Haas EM; Eikelboom T; Bouwman T
    SAR QSAR Environ Res; 2011; 22(5-6):545-59. PubMed ID: 21732893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Kernel-Based Method for Assessing Uncertainty on Individual QSAR Predictions.
    Tebby C; Mombelli E
    Mol Inform; 2012 Oct; 31(10):741-51. PubMed ID: 27476456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-Strategy Assessment of Different Uses of QSAR under REACH Analysis of Alternatives to Advance Information Transparency.
    Chinen K; Malloy T
    Int J Environ Res Public Health; 2022 Apr; 19(7):. PubMed ID: 35410019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Directions in QSAR modeling for regulatory uses in OECD member countries, EU and in Russia.
    Fjodorova N; Novich M; Vrachko M; Smirnov V; Kharchevnikova N; Zholdakova Z; Novikov S; Skvortsova N; Filimonov D; Poroikov V; Benfenati E
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2008; 26(2):201-36. PubMed ID: 18569330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison between bioconcentration factor (BCF) data provided by industry to the European Chemicals Agency (ECHA) and data derived from QSAR models.
    Petoumenou MI; Pizzo F; Cester J; Fernández A; Benfenati E
    Environ Res; 2015 Oct; 142():529-34. PubMed ID: 26282223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computer-modeling-based QSARs for analyzing experimental data on biotransformation and toxicity.
    Soffers AE; Boersma MG; Vaes WH; Vervoort J; Tyrakowska B; Hermens JL; Rietjens IM
    Toxicol In Vitro; 2001; 15(4-5):539-51. PubMed ID: 11566589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methods for reliability and uncertainty assessment and for applicability evaluations of classification- and regression-based QSARs.
    Eriksson L; Jaworska J; Worth AP; Cronin MT; McDowell RM; Gramatica P
    Environ Health Perspect; 2003 Aug; 111(10):1361-75. PubMed ID: 12896860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using toxicological evidence from QSAR models in practice.
    Benfenati E; Pardoe S; Martin T; Gonella Diaza R; Lombardo A; Manganaro A; Gissi A
    ALTEX; 2013; 30(1):19-40. PubMed ID: 23338804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using chemical categories to fill data gaps in hazard assessment.
    van Leeuwen K; Schultz TW; Henry T; Diderich B; Veith GD
    SAR QSAR Environ Res; 2009; 20(3-4):207-20. PubMed ID: 19544189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.